RCPA announces new leadership

The Royal College of Pathologists of Australasia (RCPA), has appointed Dr Lawrie Bott as its new President.

Prior to his appointment, Dr Bott held the position of RCPA Vice President for two years, from 2019 to 2021, and has served on multiple committees for the College.

“We are absolutely delighted to welcome our new RCPA President, Dr Lawrie Bott. The past two years have certainly been challenging as we navigated our way through a global pandemic, but Dr Bott was unwavering in his commitment to the College in his role as Vice President. Pathology has formed the backbone of our response to the pandemic in Australia and New Zealand. I have no doubt that Dr Bott will play a pivotal role as he guides us on the road ahead. Along with the College, I look forward to working together with him in this role,” says RCPA’s CEO, Dr Debra Graves.

Dr Bott takes over as President from Dr Michael Dray who has come to the end of his challenging two-year tenure in the role, during which he led the College through the Covid-19 pandemic. 

“On behalf of all the Fellows, Trainees and staff, we would like to thank Dr Michael Dray for his service to the College over the last two years.  It has been a difficult time to lead, especially as we faced a global pandemic, but he offered us all great support, guidance and clarity during his Presidency,” says Dr Graves.

Dr Bott is currently Chief Medical Officer of Sonic Pathology Australia, a position which he has held since 2017. He has previously been CEO for Southern IML Pathology, Wollongong, CEO of Diagnostic Services, Tasmania, and a partner then CEO at Barratt & Smith Pathology, where he covered both managerial and clinical roles.

For further information on the RCPA, please visit: www.rcpa.edu.au

312FansLike
763FollowersFollow
69FollowersFollow

Must Read

Rats

Calls for patience with ongoing RAT shortages

0
The Pharmaceutical Society of Australia (PSA) is calling for patience and understanding from the general public amidst ongoing rapid antigen tests (RAT) shortages. Stock shortages...
X